In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex 'black box' equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Art Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. "Forecasting for the Pharmaceutical Industry" is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making.

On a country-by-country basis, this publication contains listings of manufacturers authorized by Governments to manufacture narcotic drugs and psychotropic substances. Along with the name of manufacturers, readers will find their address and the name of the narcotic drugs each is manufacturer authorized to produce. A global list of narcotic drugs and psychotropic substances produced is included.

Although many books have been written about the economic impact of globalization on Europe, none has focused exclusively on the pharmaceutical industry. To fill this gap in scholarship, "Globalization and Industrial Relations" offers a full account of how open markets have affected drug companies, their employees, and consumers alike.
Using the examples of Germany and the United Kingdom as case studies, this volume uses a careful theoretical background and broad empirical analysis to evaluate the current state of industrial relations in the pharmaceutical industry. "Globalisation and Industrial Relations" addresses how companies in the pharmaceutical industry deal with the challenges from globalization in respect to collective bargaining and workplace representation. A complete analysis of industrial relations in the drug manufacturing industry in a changing world, this volume also forecasts different trajectories for the systems of industrial relations in Germany and the United Kingdom.